Not recruitingISRCTN96331501
A study on the therapeutic effect of modified electroconvulsive therapy in refractory schizophrenia
Research studyAges 18+China
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- China
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Wuhan Wudong Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN96331501
- Official title
Show the full official title
A study on the therapeutic effect of modified electroconvulsive therapy in refractory schizophrenia
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
China
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Wuhan Wudong Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
Arachidonic acid supplementation for cognitive improvement in schizophrenia: a randomized controlled trial
Arachidonic acid supplementation to improve cognitive impairment of schizophrenia